English
Segment disclosures
Company overviewBGM Group Ltd.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Ai Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:AiSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-09-30 | 3362732 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 1104733 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
Diversified Pharmaceutical And Allied Products
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:DiversifiedPharmaceuticalAndAlliedProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-09-30 | 23591893 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 9631184 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 25097951 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 46471478 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
Fertilizer
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:FertilizerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-09-30 | 905910 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 905910 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 159199 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 2000452 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 2000452 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 752672 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 1088570 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 1088570 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
Heparin Products And Sausage Casing
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:HeparinProductsAndSausageCasingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-09-30 | 2230759 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 2230759 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 1647865 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 15318798 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 15318798 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 9889832 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 23460467 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 23460467 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
Insurance Business
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:InsuranceBusinessMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-09-30 | 10964800 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 3575497 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
International Markets
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:InternationalMarketsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-09-30 | 0 | Unit_Standard_USD_5qGNWkAYVE-K6tDVpdvt5g | 20260721 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 0 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 0 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 0 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
Oxytetracycline Licorice Products And Tcmd
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=bgm:OxytetracyclineLicoriceProductsAndTcmdMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-09-30 | 21961282 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 21961282 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 10755535 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 29152228 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 29152228 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 18521112 | Unit_Standard_USD_y6npwvrUyEKJpxv5d6-NAg | 20250724 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 40305988 | Unit_Standard_USD_65e-qC6Ei0-DvNEp8CNzRg | 20250127 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 40305988 | Unit_Standard_USD_yQ1dssXcl0ClI1vGt1q97w | 20250403 | Open filing evidence |
Fertilizer
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=qli:FertilizerMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-03-31 | 159199 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 2000452 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 752672 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 1088570 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 1088570 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 677274 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 486171 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 701701 | Unit12 | 20210309 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 549231 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 549231 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 549231 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 549231 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 549231 | Unit12 | 20210309 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 713896 | Unit12 | 20210309 | Open filing evidence |
Heparin Products And Sausage Casing
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=qli:HeparinProductsAndSausageCasingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-03-31 | 1647865 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 15318798 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 9889832 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 23460467 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 23460467 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 11258349 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 23162554 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 16729115 | Unit12 | 20210309 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 15397503 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 15397503 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 15397503 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 15397503 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 15397503 | Unit12 | 20210309 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 16225787 | Unit12 | 20210309 | Open filing evidence |
International Markets
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=qli:InternationalMarketsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-03-31 | 0 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 0 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 0 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
Oxytetracycline Licorice Products And Tcmd
Statement Business Segments
Multiple units reported for the same period; values are kept separate.
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=qli:OxytetracyclineLicoriceProductsAndTcmdMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2024-03-31 | 10755535 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 29152228 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 18521112 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 40305988 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 40305988 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 20150899 | Unit_Standard_USD_EGRzYa1JLEq6NMQUAnYAmg | 20240814 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_opXSZgA-zUu2GMPEbfa67Q | 20240215 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 33451159 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit_Standard_USD_55Bw3sOpBk-lrEbHkuxehQ | 20230419 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 32602384 | Unit12 | 20210309 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 30149950 | Unit_Standard_USD_hW3I6gVqeEmknRAXEGujgQ | 20220211 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 30149950 | Unit_Standard_USD_IYtW5In98029Hy1P2JrkWA | 20220801 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 30149950 | Unit_Standard_USD_MkxiQHvf2Ei2fgg1B-hewQ | 20220630 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 30149950 | Unit_Standard_USD_t2BglgHGeUShLio38qHYcg | 20221013 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 30149950 | Unit12 | 20210309 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 33429330 | Unit12 | 20210309 | Open filing evidence |